Full-Time

Staff Software Engineer/Bioinformatician

Posted on 8/8/2024

GeneDx

GeneDx

501-1,000 employees

Genetic testing for rare disease diagnostics

Compensation Overview

$183.7k - $229.6k/yr

Senior

Remote in USA

Category
Bioinformatics
Biology & Biotech
Software QA & Testing
Software Engineering
Required Skills
Kubernetes
Python
Docker
AWS
Requirements
  • Proficiency in Python; comfortable with working in other similar languages.
  • Experience building/consuming API calls/responses and ETL functions.
  • Experience with AWS services, Docker, Kubernetes, Helm, CI/CD, automated testing, and data logging suites/toolsets.
  • Good understanding of general software engineering patterns, best practices, and methods.
  • 8+ years professional experience (industry setting) designing and supporting robust applications using modern object-oriented frameworks.
  • Able to define and execute work across platforms over multiple quarters, as a technical project lead and contributor.
  • Have developed novel bioinformatics algorithms and products.
  • Track record of influential publications or leadership of scientific collaborations.
  • Successful history of delivering scalable production software.
  • Excellent communication skills; ability to work collaboratively with other development teams.
  • Knowledge of bioinformatics pipeline scalability, observability, and cost efficiency.
  • Be able to lead, coordinate, and execute validation efforts for new products.
  • Deep understanding of technical implementation of complex variant calling - structural variants beyond copy number.
  • Ability to improve existing variant calling algorithms.
  • Technical knowledge of NGS and non-NGS laboratory assays.
  • Prior experience working in a CAP/CLIA regulated setting.
  • Prior experience preparing for a CAP/CLIA inspection.
  • Understanding of assay panel design considerations.
  • Able to coordinate and execute efforts for modifications to existing bioinformatics products.
  • Experience troubleshooting wet-lab and dry-lab issues.
  • Strong understanding of bayesian statistics and ML in relation to common bioinformatics applications.
  • Familiarity with samtools, gatk, picard, vcftools, bedtools.
  • Familiarity with bioinformatics workflow management tools and concepts.
  • PhD strongly preferred.
Responsibilities
  • Design, write, and maintain high quality and robust software applications and services to meet team goals.
  • Design novel algorithms in support of new product offerings, lead analytical validation efforts in support of existing pipeline improvements.
  • Collaborate with teammates and product managers in developing development roadmaps and sprint planning.
  • Lead establishment and adherence to robust and compliant software development best practices.
  • Participate in software quality testing and validation.
  • Participate in cross-functional development with other teams.
  • Contribute to continuous improvement in the operating model of the team.
  • Level up your teammates to bring deeper understanding of technical know-how across teams.
  • Ensure quality technical implementation within our platform.
  • Your code is peer-reviewed through the pull request process. You lead reviews of others’ work.
  • Produce high quality code that meets company coding standards and is clearly written and documented so that other software developers can work with it.

GeneDx specializes in genetic testing to diagnose rare diseases by analyzing patients' DNA for mutations linked to health conditions. The company collects DNA samples through cheek swabs, blood, or other specimens and sequences them to identify genetic variations. With over 300,000 clinical patient exomes sequenced, GeneDx provides rapid testing services, including products like GenomeXpress and XomeDx Xpress, which deliver results in as little as seven days. This quick turnaround is crucial for timely diagnoses that can improve treatment outcomes and reduce healthcare costs. Unlike competitors, GeneDx focuses on personalized medicine and offers digital Patient Letters to help patients and families understand their genetic information. The company's goal is to enhance the diagnosis and management of genetic conditions through accurate and efficient testing.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Gaithersburg, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-powered Multiscore tool improves clinical analysis and patient outcomes.
  • Integration with Epic Aura streamlines genomic testing in healthcare systems.
  • Recognition as a top innovative company boosts GeneDx's industry reputation.

What critics are saying

  • Emerging competitors may challenge GeneDx's market position with innovative technologies.
  • Data privacy concerns could undermine trust in GeneDx's services.
  • Regulatory changes may increase compliance costs for GeneDx.

What makes GeneDx unique

  • GeneDx integrates AI with genomic data for enhanced diagnostic efficiency.
  • Centrellis platform synthesizes clinical and genomic data for personalized insights.
  • GeneDx Discover tool accelerates drug discovery with vast genetic datasets.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

401(k) Retirement Plan

Employee Discounts

Voluntary benefits

Company News

Stock Titan
Mar 18th, 2025
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

GAITHERSBURG, Md.-(BUSINESS WIRE)- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today they have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025, and recognized as the No. 2 in the Biotech category.

The Chemical Data Company
Mar 13th, 2025
GeneDx to Present Key Research at 2025 ACMG Annual Meeting

GeneDx Showcases Groundbreaking Genomic Research at 2025 ACMG Annual Clinical Genetics Meeting

Stock Titan
Mar 13th, 2025
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GAITHERSBURG, Md.-(BUSINESS WIRE)- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights.

Hit Consultant
Mar 13th, 2025
Genedx Launches Multiscore: Ai-Powered Tool For Genetic Analysis

What You Should Know: – GeneDx, a leader in delivering improved health outcomes through genomic insights launches Multiscore, an advanced AI-powered decision support tool. – Multiscore is designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights.Advanced Decision Support System Enhances Diagnostic Efficiency Embedded into GeneDx’s interpretation platform, Multiscore acts as a decision support tool, helping clinical geneticists focus on the most relevant genes during their clinical analysis. This innovation will be presented at the ACMG (American College of Medical Genetics and Genomics) meeting in a session titled: “Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in 10,000 Exomes and Genomes,” which was selected for a limited-spot industry-specific platform session.Leveraging AI and Extensive Data for Enhanced Gene RankingMultiscore utilizes a powerful combination of GeneDx’s industry-leading proprietary dataset, publicly available data, and advanced AI to prioritize genes in exome and genome sequences. This prioritization is based on how well the genes align with a patient’s clinical presentation. By incorporating phenotypic similarities into gene ranking criteria, GeneDx can better serve patients whose symptoms may deviate from textbook descriptions. This approach also facilitates the identification of pathogenic or likely pathogenic diagnoses in complex cases.Transforming Genetic Analysis with AIMultiscore’s ability to incorporate phenotypic similarities into gene ranking is particularly significant, as it addresses the challenge of diagnosing patients with atypical symptoms. This AI-driven approach ensures that even complex cases can be analyzed efficiently and accurately.By leveraging the power of AI and its vast database, GeneDx is empowering clinical geneticists to make more informed decisions, ultimately improving patient outcomes

Stock Titan
Feb 12th, 2025
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

GAITHERSBURG, Md.-(BUSINESS WIRE)- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 45th Annual TD Cowen Health Care Conference from March 3-5 in Boston, MA.

INACTIVE